scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.AMJCARD.2009.10.064 |
P698 | PubMed publication ID | 20211326 |
P50 | author | Zhenyi Xue | Q114406231 |
Ron Waksman | Q7364511 | ||
Gilles Lemesle | Q56973448 | ||
Sara Collins | Q74423065 | ||
Lowell F Satler | Q88227547 | ||
Gabriel Maluenda | Q88840517 | ||
Augusto D Pichard | Q106695449 | ||
Rebecca Torguson | Q106695518 | ||
Kenneth M Kent | Q106695575 | ||
William O Suddath | Q106695580 | ||
Asmir I Syed | Q114406228 | ||
I Itsik Ben-Dor | Q114406229 | ||
Kimberly Kaneshige | Q114406230 | ||
P2093 | author name string | Joseph Lindsay | |
Cedric Delhaye | |||
Kohei Wakabayashi | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 826-832 | |
P577 | publication date | 2010-03-01 | |
P1433 | published in | American Journal of Cardiology | Q2208417 |
P1476 | title | Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation | |
P478 | volume | 105 |
Q43505647 | Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis |
Q64082486 | Associations among circulating levels of follistatin-like 1, clinical parameters, and cardiovascular events in patients undergoing elective percutaneous coronary intervention with drug-eluting stents |
Q36013281 | Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis |
Q37259541 | Effects of low dose pioglitazone on restenosis and coronary atherosclerosis in diabetic patients undergoing drug eluting stent implantation |
Q39680106 | Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention |
Q34634358 | High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials |
Q39240862 | Interleukin-6, but not C-reactive protein, predicts the occurrence of cardiovascular events after drug-eluting stent for unstable angina |
Q57445651 | Lipoprotein(a), Interleukin-10, C-Reactive Protein, and 8-Year Outcome After Percutaneous Coronary Intervention |
Q85776838 | Role of pre-procedural C-reactive protein level in the prediction of major adverse cardiac events in patients undergoing percutaneous coronary intervention: a meta-analysisof longitudinal studies |
Q55428692 | Statin in the treatment of patients with myocardial infarction: A meta-analysis. |
Q84535196 | Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting |
Search more.